The Latest Breaking News from AstraZeneca

Only 20% of the top 1,000 companies have targets to reduce their emissions, a sign not enough leaders are taking climate change seriously.

A multi-million-pound landmark “vaccine damage” case is set to take place in London’s High Court. The test case is being pursued by Jamie Scott who suffered a severe brain injury in April 2021 after receiving the Oxford-AstraZeneca vaccine.

AZN stock popped after AstraZeneca said it would spend up to $2.01 billion to license an experimental weight-loss drug from Eccogene.

UK drugmaker signs agreement with China’s Eccogene to work on an obesity and type 2 diabetes pill

Shares in FTSE 100 heavyweight Diageo have tumbled after it cut guidance due to lower-than-expected demand in Latin America and the Caribbean.

AstraZeneca in partnership with the University of Oxford developed one of the first vaccines against COVID. The vaccine, which used an adenovirus to smuggle instructions into human cells to make antibodies against the novel coronavirus, saved countless lives. But a problem soon emerged. A tiny proportion – about one in…

Victorians have been warned to prepare for the possibility of thunderstorm asthma again this season.

A new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should prioritize giving the drug to babies at the highest risk of severe disease

AstraZeneca stock tumbled Wednesday after its experimental drug led to only a month's benefit over chemotherapy in lung cancer patients.

AstraZeneca and Daiichi Sankyo said Friday their breast cancer treatment outperformed chemo in a Phase 3 study, and AZN stock jumped.

It might be the first time we’ve said this with no equivocation: Scott Morrison is absolutely right. Here are some major decisions in the management of COVID-19 the ALP doesn’t have an interest in looking into.